Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy symbols : Biib save search
New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy
Published: 2024-03-06 (Crawled : 12:30) - globenewswire.com
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.05%
H: 1.32%
C: 0.18%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.11%
H: 1.16%
C: 0.04%
spinraza biomarker potential therapy
Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP
Published: 2024-02-23 (Crawled : 12:00) - globenewswire.com
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.25%
H: 2.95%
C: 2.88%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.43%
H: 1.06%
C: -0.05%
qalsody first chmp genetic positive treat therapy
Biogen Received European Commission Approval for SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia
Published: 2024-02-12 (Crawled : 21:00) - globenewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -3.72%
H: 0.58%
C: -3.82%
skyclarys first approval treat therapy
CHMP Issues Positive Opinion for Biogen’s SKYCLARYS® (omaveloxolone), the First Therapy to Treat Friedreich’s Ataxia, a Rare Neurodegenerative Disease
Published: 2023-12-15 (Crawled : 14:00) - globenewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.31%
H: 0.98%
C: -3.58%
skyclarys rare first disease chmp positive treat neurodegenerative therapy
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute 39% to the growth - Technavio
Published: 2023-12-12 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.56%
H: 0.51%
C: 0.51%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -5.13%
H: 5.41%
C: 3.46%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.45%
H: 0.75%
C: 0.46%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.18%
H: 0.43%
C: 0.25%
GBIO | $2.81 1.08% 1.07% 250K
|
Health Technology
|
| O: 5.62%
H: 3.72%
C: -4.26%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.59%
H: 1.35%
C: 0.6%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 1.83%
H: 0.04%
C: -1.13%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: -0.46%
H: 5.56%
C: -1.12%
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: 0.65%
H: 2.59%
C: 0.86%
america therapy growth market
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for CVDs and orphan diseases is the major market trend- Technavio
Published: 2023-12-01 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: 3.87%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -3.37%
H: 4.51%
C: 4.51%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.25%
H: 0.68%
C: 0.48%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
GBIO | $2.81 1.08% 1.07% 250K
|
Health Technology
|
| O: 0.0%
H: 38.05%
C: 23.01%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.06%
H: 0.35%
C: 0.29%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.12%
H: 0.97%
C: 0.92%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: -5.76%
H: 16.36%
C: 15.07%
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -2.43%
H: 0.0%
C: 0.0%
research growing therapy market
Gene Therapy Market size to grow by USD 4.61 billion from 2022 to 2027, North America to account for 39% of market growth- Technavio
Published: 2023-11-03 (Crawled : 23:00) - prnewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
ALPMF | $9.17 43.47% 16K
|
Health Technology
| Email alert
Add to watchlist
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
GBIO | $2.81 1.08% 1.07% 250K
|
Health Technology
| Email alert
Add to watchlist
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
| Email alert
Add to watchlist
AAPL | News S | $164.96 -1.24% -1.32% 67M
|
Electronic Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
| Email alert
Add to watchlist
america therapy market
New Data at Cure SMA Highlight Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs After Gene Therapy
Published: 2023-06-30 (Crawled : 20:00) - globenewswire.com
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
| Email alert
Add to watchlist
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
| Email alert
Add to watchlist
spinraza potential therapy
Gene Therapy Market size is set to grow by USD 4,613.9 million from 2022 to 2027; Increase in special drug designations boosts the market growth - Technavio
Published: 2023-06-12 (Crawled : 15:00) - prnewswire.com
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -0.68%
H: 3.23%
C: 1.55%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.16%
H: 0.11%
C: -0.76%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.62%
H: 4.57%
C: 2.04%
GBIO | $2.81 1.08% 1.07% 250K
|
Health Technology
|
| O: 0.0%
H: 11.57%
C: 6.4%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: -1.99%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: -0.86%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: -0.75%
H: 7.14%
C: 6.12%
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: 0.0%
H: 4.4%
C: 3.29%
drug set therapy growth market
CANbridge Pharmaceuticals Appoints Jason West Vice President, Head of Gene Therapy Research
Published: 2023-05-05 (Crawled : 09:00) - biospace.com/
CRSP M | $55.04 -1.99% -2.03% 1.8M
|
Health Technology
|
| O: 1.88%
H: 6.97%
C: 3.09%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.08%
H: 1.89%
C: 1.35%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.33%
H: 1.88%
C: 1.66%
west pharmaceuticals research therapy
EISAI PUBLISHES LONG-TERM HEALTH OUTCOMES USING SIMULATION MODEL OF LECANEMAB USING PHASE 3 CLARITY AD DATA IN PEER-REVIEWED NEUROLOGY AND THERAPY JOURNAL
Published: 2023-04-03 (Crawled : 00:00) - prnewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.08%
H: 0.17%
C: -0.67%
health lecanemab therapy
EISAI PUBLISHES SOCIETAL VALUE OF LECANEMAB USING PHASE 3 CLARITY AD DATA IN PEER-REVIEWED NEUROLOGY AND THERAPY JOURNAL
Published: 2023-03-19 (Crawled : 00:00) - prnewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.57%
H: 1.56%
C: 1.23%
lecanemab therapy
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027; The increase in special drug designations to drive growth- Technavio
Published: 2023-03-16 (Crawled : 02:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.16%
H: 0.73%
C: 0.73%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 0.44%
H: 0.29%
C: 0.29%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.18%
H: 0.77%
C: 0.64%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -4.62%
H: 4.44%
C: -6.05%
GBIO | $2.81 1.08% 1.07% 250K
|
Health Technology
|
| O: -0.55%
H: 6.69%
C: 1.95%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -1.11%
H: 2.97%
C: 2.23%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.49%
H: 0.39%
C: 0.36%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: -2.65%
H: 14.55%
C: 9.09%
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: -2.29%
H: 3.52%
C: -0.78%
drug therapy market
Global Gene Therapy Market to Grow by $4.61 Billion During 2023-2027
Published: 2023-03-14 (Crawled : 01:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 1.01%
H: 0.43%
C: 0.29%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.28%
H: 0.38%
C: 0.31%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.01%
H: 7.6%
C: 7.6%
GBIO | $2.81 1.08% 1.07% 250K
|
Health Technology
|
| O: 3.79%
H: 2.61%
C: -1.57%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 1.4%
H: 1.39%
C: 0.07%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: -1.23%
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 0.9%
H: 4.46%
C: 2.68%
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
|
| O: 2.79%
H: 8.53%
C: 0.78%
global therapy market
Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published: 2023-01-18 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: -1.68%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.5%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.16%
H: 1.62%
C: -0.54%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.17%
H: 0.25%
C: -2.96%
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.56%
H: 0.97%
C: -1.87%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.57%
H: 0.84%
C: -0.01%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.93%
H: 0.01%
C: -1.16%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.41%
H: 0.2%
C: -1.1%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.17%
C: -1.01%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.4%
H: 0.75%
C: -1.21%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.16%
H: 0.33%
C: -1.5%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.34%
H: 0.46%
C: -2.45%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.36%
H: 0.33%
C: -1.13%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.0%
H: 0.41%
C: -1.87%
therapy growth
Global Gene Therapy Market Report to 2028 - Industry Analysis, Trends, Market Size and Forecasts
Published: 2022-09-23 (Crawled : 15:20) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 5.45%
H: 0.0%
C: -8.46%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.06%
H: 0.39%
C: -0.41%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.69%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.44%
H: 0.46%
C: -0.99%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: -0.17%
H: 0.17%
C: -1.25%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.11%
H: 0.27%
C: -0.45%
global report therapy market
Worldwide Gene Therapy Industry to 2027 - Players Include Amgen, Biogen and Novartis Among Others
Published: 2022-03-04 (Crawled : 21:00) - prnewswire.com
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
| Email alert
Add to watchlist
ABEO | $7.6 0.93% 0.92% 390K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
| Email alert
Add to watchlist
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
| Email alert
Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
| Email alert
Add to watchlist
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
ALPMF | $9.17 43.47% 16K
|
Health Technology
| Email alert
Add to watchlist
novartis gene therapy therapy
INVESTIGATIONAL ALZHEIMER'S DISEASE THERAPY LECANEMAB GRANTED FDA FAST TRACK DESIGNATION
Published: 2021-12-23 (Crawled : 01:00) - prnewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
| Email alert
Add to watchlist
alzheimer fast track designation fda ema fast track granted disease fda fast track therapy alzheimer’s alzheimer's disease grant alzheimer's designation lecanemab
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
Published: 2021-10-27 (Crawled : 20:00) - fda.gov
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.44%
H: 2.01%
C: 0.82%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 2.03%
H: 3.33%
C: 0.07%
RGNX | $15.67 -2.73% -2.87% 570K
|
Health Technology
|
| O: 0.91%
H: 2.93%
C: 2.79%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.19%
H: 2.32%
C: 1.7%
disease fda gene therapies therapy gene therapy rare
Global $21.2 Bn Advanced Therapy Medicinal Products Market to 2028: Breakthrough Approvals of Tecartus and Abecma Post-approval of Zolgensma, Kymriah, and Yescarta have Bolstered Rapid Advancements
Published: 2021-09-23 (Crawled : 12:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.92%
H: 0.5%
C: 0.01%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.42%
H: 1.55%
C: 0.38%
VCEL | $43.74 -0.27% -0.27% 520K
|
Health Technology
|
| O: 0.86%
H: 2.12%
C: 1.89%
QURE | $4.68 -0.64% -0.64% 550K
|
Health Technology
|
| O: 0.5%
H: 0.58%
C: -5.62%
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: 1.11%
H: 2.8%
C: 2.53%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 1.51%
H: 2.09%
C: -0.17%
therapy approval
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.